Approval · Notice of Compliance 2952 · 2004
GEN-HYDROXYCHLOROQUINE: Notice of Compliance 2952
Issued May 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2952
- Date
- May 21, 2004
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anti-rheumatic, antimalarial
- Canadian reference product
- PLAQUENIL (Sanofi Winthrop Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-HYDROXYCHLOROQUINE | 02252600 | Cancelled Post Market |
Medicinal ingredients
- HYDROXYCHLOROQUINE SULFATE 200 MG per TAB